Please use one of the following formats to cite this article in your essay, paper or report: APA. Lightfoot, Colin. (2023, May 01). Safety and oral immunogenicity of a VSV-derived mucosal vaccine ...

A retroviral vector constructed from the murine leukemia virus (MLV) can only express transgenes in cells undergoing mitosis, indicating its suitability as a delivery vehicle for cancer gene therapy.

In vivo therapy is not associated with a replicative burst in B16ova tumors. In vitro, VSV replicates rapidly to high titers in B16ova cells (Figure 1a, right) leading to infection between 90 and ...